Vasant Narasimhan Biography
Vasant Narasimhan is the CEO of Novartis and an Indian-American physician. He is the CEO of a company with approximately 100,000 employees that operate in over 150 countries and will provide medicines to 766 million patients in 2021.
Vasant Narasimhan’s Age
Narasimhan is 46 years old as of August 2022. He was born Vasant “Vas” Narasimhan on 26 August 1976 in Pittsburgh, Pennsylvania, United States.
Vasant Narasimhan Education
Narasimhan earned a bachelor’s degree in biological sciences from the University of Chicago, a medical degree from Harvard Medical School, and a master’s degree in public policy from the John F. Kennedy School of Government.
Vasant Narasimhan Height
Narasimhan stands at an average height of 6 feet 0 inches tall.
Vasant Narasimhan Family – Parents
Narasimhan was the son of Kalathur and Gita Narasimhan. Gita Narasimhan, a former nuclear engineer for Public Service Electric & Gas, is now a physics lecturer at Burlington County Community College in Pemberton, New Jersey. His father works as vice president for research and development at the Hoeganaes Corporation in Cinnaminson, New Jersey, a developer and supplier of industrial raw materials.
Vasant Narasimhan Wife
Narasimhan is happily married to Srishi Gupta, a daughter of Dr. and Mrs. Jagdish K. Gupta of Roslyn, N.Y.. Together they married at Antun’s Catering in Hicksville, N.Y.
Vasant Narasimhan Career
Narasimhan joined McKinsey & Co, Inc. after graduating from Harvard. Novartis later approached him in 2005. From 2014 to 2016, he was the global head of development at Novartis Pharmaceuticals. From 2016 to 2018, he was the company’s Chief Medical Officer and Global Head of Drug Development. On September 5, 2017, he was appointed to succeed Joseph Jimenez as CEO of Novartis. Novartis AG is a multinational pharmaceutical company headquartered in Basel, Switzerland, and with offices in Cambridge, Massachusetts, USA (global research). The pharmaceutical company is one of the largest in the world. Clozapine (marketed under the brand name Clozaril), diclofenac (Voltaren; sold to GlaxoSmithKline in a 2015 deal), carbamazepine (marketed under the brand name Tegretol), valsartan (marketed under the brand name Diovan), and imatinib mesylate (marketed under the brand name Gleevec/Glivec) cyclosporine (marketed as Neoral/Sandimmune), letrozole (marketed as Femara), methylpheni
In March 1996, the companies Ciba-Geigy and Sandoz merged to form Novartis. The pharmaceutical and agrochemical divisions of Novartis formed an independent company. Other Ciba-Geigy and Sandoz businesses, like Ciba Specialty Chemicals, were sold or spun off as separate entities. After going extinct for three years, Novartis resurrected the Sandoz brand in 2003 when it combined its generic drug businesses into a single subsidiary and renamed it Sandoz. When Syngenta was spun off in a joint venture with AstraZeneca, which had previously sold its agrochemical division, Novartis sold its agrochemical and genetically modified crop businesses in 2000. The Pharmaceutical Research and Manufacturers of America has accepted Novartis as a full member (PhRMA) (PhRMA), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), and the European Federation of Pharmaceutical Industries and Associations (EFPIA)[5] (PhRMA).
Vasant Narasimhan Salary
His salary is not yet disclosed.
Vasant Narasimhan Net Worth
Narasimhan has an estimated net worth of $5 Million.
